Patient-specific tumor dosimetry in mCRPC patients treated with 177Lu-PSMA-617

被引：0
|
作者：
Meyer, Catherine [1 ]
Mirando, David [2 ]
Adams, Tim [2 ]
Czernin, Johannes [1 ]
Calais, Jeremie [1 ]
Dahlbom, Magnus [1 ]
机构：
[1] Univ Calif Los Angeles, Ahmanson Translat Imaging Div, Los Angeles, CA USA
[2] MIM Software Inc, Cleveland, OH USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2021年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1572
引用
收藏
页数：2
相关论文
共 50 条
  • [1] 177Lu-PSMA-617 vs Cabazitaxel in MCRPC
    不详
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (04) : 13N - 13N
  • [2] Radiation Dosimetry in 177Lu-PSMA-617 Therapy
    Jackson, Price
    Hofman, Michael
    McIntosh, Lachlan
    Buteau, James Patrick
    Kumar, Aravind Ravi
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (02) : 243 - 254
  • [3] Patient-specific kidney absorbed doses in mCRPC patients treated with 177Lu-PSMA-617: a post-hoc analysis of a prospective phase 2 study
    Meyer, C.
    Mirando, D.
    Adams, T.
    Ranganathan, D.
    Esfandiari, R.
    Delpassand, E.
    Czernin, J.
    Calais, J.
    Dahlbom, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S382 - S382
  • [4] 177Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of response
    Kambiz Rahbar
    Martin Bögemann
    Hojjat Ahmadzadehfar
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2017, 44 : 166 - 167
  • [5] 177Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of response
    Rahbar, Kambiz
    Boegemann, Martin
    Ahmadzadehfar, Hojjat
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (01) : 166 - 167
  • [6] Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions
    Wang, Jingnan
    Zang, Jie
    Wang, Hao
    Liu, Qingxing
    Li, Fang
    Lin, Yansong
    Huo, Li
    Jacobson, Orit
    Niu, Gang
    Fan, Xinrong
    Zhu, Zhaohui
    Chen, Xiaoyuan
    [J]. CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : 431 - 438
  • [7] Cocktail Therapy of 177Lu-PSMA-617 and 177Lu-EDTMP in Patients With mCRPC A Proof-of-Principle Application
    Bal, Chandrasekhar
    Yadav, Madhav Prasad
    Ballal, Sanjana
    [J]. CLINICAL NUCLEAR MEDICINE, 2016, 41 (08) : E386 - E387
  • [8] 177Lu-PSMA-617: Brazilian Experience
    Villas Boas, Cristian Wieczorek
    Silva, Jefferson de Jesus
    Benedetto, Raquel
    Mengatti, Jair
    De Araujo, Elaine Bortoleti
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [9] Dosimetry in a patient with peritoneal dialysis treated with [177Lu]Lu-PSMA-617
    Glass, Kathrin
    Hendrik Hering, Andreas
    Heinzel, Alexander
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2024, 63 (03): : 221 - 223
  • [10] 177Lu-PSMA-617 radioligand therapy in mCRPC: ready for phase III trial?
    Kambiz Rahbar
    Hojjat Ahmadzadehfar
    Martin Boegemann
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 513 - 514
12345